
Pelago Bioscience
Solna, Sweden pelagobio.com
From their website, Nov 2026
Work here? Claim this listing
About
Pelago Bioscience provides CETSA-based drug discovery services that measure target engagement in cells, lysates, tissues, whole blood, and other complex biological systems. It serves drug discovery and development teams working from early target discovery through lead optimization, translational studies, and preclinical studies. The company is based in Solna, Sweden, within the Karolinska Institute life science campus.
Services
Proteome-wide CETSA
Observes how a compound influences proteins and pathways across the proteome without relying on predefined targets or assumptions.
CETSA Deconvolution
Uses mass spectrometry to measure compound-induced changes across thousands of proteins simultaneously to identify direct target engagement, pathway responses, and off-target effects.
CETSA Selectivity
Compares compounds across the proteome to reveal shared, distinct, and unexpected thermal stability response patterns for selectivity profiling.
Targeted Services
Measures thermal stability changes in defined proteins to validate mechanistic hypotheses and confirm on-target engagement in the intended cellular context.
Primary Screening
Screens compound libraries in cells to identify starting points for new therapeutic programs and select hits with meaningful activity in biologically relevant contexts.
Hit Confirmation
Retests preliminary hits to verify reproducible target engagement and support progression into follow-up studies and SAR analysis.
Potency Ranking
Ranks compounds in cells using concentration-response data and EC50 estimates to prioritize compounds and chemical series.
Selectivity Profiling
Profiles on- and off-target activity across the proteome to support compound optimization and prioritization.
Target Identification and Deconvolution
Identifies which biological targets drive an observed effect and separates direct target effects from downstream pathway responses or assay artifacts.
Mechanism of Action
Examines pathway-level responses and network interactions to place compound activity in biological context.
Translational Studies
Assesses whether cellular target engagement and exposure-response relationships are maintained in tissues and more complex biological systems.
In Vivo Target Engagement
Verifies target engagement in live tissue under physiological conditions.
Biomarker Discovery
Identifies proteome-level patterns that can serve as pharmacodynamic readouts or guide model selection.
- Turnaround
- 10 working days
- What to send
- Intact cells or lysates · Tissues · Whole blood
Capabilities
- Assays and studies
- Cell-based assays · Small molecules · Cellular Thermal Shift Assay (CETSA) · Mass spectrometry-based profiling · Immunodetection · Concentration-response experiments · Thermal stability profiling
- Scale and capacity
- Thousands of proteins · 350+ customers · 750+ CETSA projects · 800+ references annually · Thousands of proteins simultaneously
- Therapeutic areas
- Drug discovery · Cancer · Antimalarial · Fungal · Oncology
Instruments and platforms
- Mass spectrometry
- Automated proteomics
- Bioinformatics
- High-throughput screening
Modalities and species
- Modalities
- Small molecule
- Species and models
- Intact cells · Lysates · Disease-relevant cells · Whole blood · Tissues · Cell lines · Animal tissues · Human-derived systems · Human primary cells · Native proteins
Industries served
- Pharma
- Drug discovery
Company
- Founded
- 2013
- Ownership
- Small business, as registered with SAM.gov or stated on their site
Locations
- Based in
- Solna, Sweden
- Sites
- Solna, Sweden · Stockholm, Sweden
Similar labs
Work here? Claim this listing